Korean Firm Draws FDA Warning for GMP Violations, Mislabeling

Drug Industry Daily
A A
The FDA warned a Korean manufacturer over significant GMP violations observed during an inspection in March, including its failure to test incoming components.

To View This Article:

Login

Subscribe To Drug Industry Daily